abagovomab 44
abciximab 40
abituzumab 31
abrilumab 28
actoxumab 29
adalimumab 22
aducanumab 17
afasevikumab 23
alacizumab_pegol 16
alemtuzumab 39
alirocumab 25
amatuximab 54
andecaliximab 31
anifrolumab 30
anrukinzumab 24
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 26
ascrinvacumab 14
atezolizumab 16
atinumab 21
avelumab 19
basiliximab 47
bavituximab 47
begelomab 38
benralizumab 36
bevacizumab_beta 27
bezlotoxumab 29
bimagrumab 26
bleselumab 26
blinatumomab 43
blosozumab 36
bococizumab 26
brazikumab 20
brentuximab_vedotin 43
briakinumab 22
brodalumab 26
brolucizumab 31
brontictuzumab 31
burosumab 26
cabiralizumab 33
camrelizumab 17
canakinumab 29
cantuzumab_ravtansin 56
carlumab 22
carotuximab 32
cergutuzumab_amunaleukin2 36
cergutuzumab_amunaleukin 36
certolizumab_pegol 27
cetiximab 53
citatuzumab_bogatox 30
cixutumumab 38
clivatuzumab_tetraxetan 35
codrituzumab 36
conatumumab 20
concizumab 35
crenezumab 25
crizanlizumab 31
crotedumab 24
dacetuzumab 26
daclizumab 24
dalotuzumab 48
dapirolizumab_pegol 30
daratumumab 17
dectrekumab 13
demcizumab 35
denosumab 12
depatuxizumab 34
depatuxizumab_mafodotin 34
dezamizumab 27
dinutuximab 46
diridavumab 34
domagrozumab 20
drozitumab 28
duligotuzumab 21
durvalumab 18
dusigitumab 32
efalizumab 38
efungumab 35
eldelumab 22
elezanumab 30
elgemtumab 15
elotuzumab 23
emactuzumab 31
emapalumab 32
emibetuzumab 30
enavatuzumab 28
enfortumab_vedotin 16
enoblituzumab 23
enokizumab 31
enoticumab 24
ensituximab 44
eptinezumab 21
erenumab 28
etaracizumab 19
etrolizumab 25
evinacumab 25
evolocumab 29
farletuzumab 17
fasinumab 32
fezakinumab 29
fibatuzumab 19
ficlatuzumab 32
firivumab 42
flanvotumab 29
fletikumab 36
foralumab 20
foravirumab 19
fremanezumab 35
fresolimumab 25
fulranumab 24
futuximab 39
galcanezumab 24
ganitumab 35
gantenerumab 16
gemetuzumab 39
gemtuzumab2 37
gemtuzumab 35
gevokizumab 31
girentuximab 36
glembatumumab 27
glembatumumab_vedotin 27
guselkumab 28
ibalizumab 36
ibritumomab 47
icrucumab 18
idarucizumab 43
ifabotuzumab 19
imalumab 19
imgatuzumab 31
inclacumab 25
indatuximab_ravtansin 45
indusatumab 25
inebilizumab 32
intetumumab 22
iodine_girentuximab 33
ipilimumab 11
iratumumab 20
isatuximab 45
itolizumab 30
ixekizumab 39
labetuzumab_govitecan 29
lambrolizumab 35
lampalizumab 32
lanadelumab 19
landogrozumab 20
laprituximab 35
lebrikizumab 42
lendalizumab 28
lenzilumab 24
lifastuzumab_vedotin 27
ligelizumab 30
lilotomab 49
lirilumab 30
lodelcizumab 23
lokivetmab 29
lorvotuzumab_mertansin 30
lucatumumab 33
lumretuzumab 26
lupartumab 20
lutikizumab 23
margetuximab 45
milatuzumab 50
mirvetuximab 46
mirvetuximab_soravtansin 46
modotuximab 50
mogamulizumab 37
monalizumab 29
motavizumab 44
moxetumomab_pasudotox 35
namilumab 35
naratuximab 38
naratuximab_emtansin 38
narnatumab 25
navicixizumab2 31
navicixizumab 36
navivumab 44
necitumumab 18
nemolizumab 33
nesvacumab 21
nivolumab 20
obiltoxaximab 27
obinutuzumab 38
ocaratuzumab 32
ofatumumab 23
olaratumab 27
olokizumab 28
omalizumab 22
onartuzumab 27
ontuxizumab 38
opicinumab 17
orticumab 17
otelixizumab 44
oxelumab 14
ozanezumab 38
pamrevlumab 14
panobacumab 32
parsatuzumab 32
pasotuxizumab 23
pateclizumab 22
patritumab 32
pembrolizumab 35
perakizumab 26
pidilizumab 30
pinatuzumab_vedotin 19
plozalizumab 34
pogalizumab 29
polatuzumab_vedotin 24
ponezumab 46
prezalumab 18
pritoxaximab 52
quilizumab 23
racotumomab 40
radretumab 19
ralpancizumab 28
ramucirumab 17
ranevetmab 35
ranibizumab 27
refanezumab 30
remtolumab 21
rilotumumab 29
rinucumab 28
risankizumab 41
rituximab 29
rivabazumab 27
robatumumab 21
roledumab 37
romosozumab 32
rontalizumab 27
rosmantuzumab 31
rozanolixizumab 27
sacituzumab 40
sacituzumab_govitecan 40
samalizumab 31
sapelizumab 25
sarilumab 19
secukinumab 24
seribantumab 20
setoxaximab 55
sifalimumab 25
siltuximab 36
simtuzumab 34
sirukumab 18
solanezumab 29
solitomab 37
stamulumab 28
suptavumab 31
suvizumab 28
tabalumab 26
tadocizumab 24
tamtuvetmab 40
tanezumab 30
tarextumab 16
tavolixizumab 27
telisotuzumab 35
teplizumab 28
tesidolumab 39
tezepelumab 35
tigatuzumab 20
tildrakizumab 26
timolumab 21
tisotumab 17
tosatoxumab 46
tositumomab 44
tralokinumab 41
trastuzumab 24
tregalizumab 25
trevogrumab 15
ublituximab 39
urelumab 32
ustekinumab 34
utomilumab 36
vadastuximab 34
vadastuximab_talirin 34
vandortuzumab_vedotin 24
vantictumab 31
vanucizumab2 27
vanucizumab 42
varlilumab 20
vatelizumab 30
vedolizumab 41
veltuzumab 26
vesencumab 13
vorsetuzumab 28
vorsetuzumab_mafodotin 28
vunakizumab 47
xentuzumab 23
zatuximab 50
